Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
What’s Your Call?
Collective community sentiment on Sanjivani Paranteral Ltd
Your Vote -
Buy
50.00%
Hold
0.00%
Sell
50.00%
50.00%
4 users have voted
Option Chain
Analyzes market sentiment, predicts Sanjivani Paranteral Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Sanjivani Paranteral - Board Meeting Outcome for Outcome Of Board Meeting Held On Thursday, 21St May, 2026
-
Sanjivani Paranteral - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
-
Sanjivani Paranteral - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
-
Sanjivani Paranteral - Announcement under Regulation 30 (LODR)-Press Release / Media Release
-
Sanjivani Paranteral - Board Meeting Intimation for Intimation Of Notice Of Board Meeting To Be Held On Thursday, 21St May, 2
-
Sanjivani Paranteral - Announcement under Regulation 30 (LODR)-Investor Presentation
-
Sanjivani Paranteral Q4 net profit down 57.08% at Rs 0.94 cr
-
Sanjivani parant - Audited Standalone And Consolidated Financial Results Along With Audit Report For The Fourth Quarter And F
-
Sanjivani parant - Board Meeting Outcome for Outcome Of Board Meeting Held On Thursday, 14Th May, 2026.
-
Sanjivani parant - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Sanjivani parant - Board Meeting Intimation for Approval Of Audited Standalone And Consolidated Financial Results Along With
-
Sanjivani parant - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
-
Sanjivani parant has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2026
-
Sanjivani parant - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
-
Sanjivani parant - Disclosure Under Regulation 31(4) Of The Securities Exchange Board Of India (Substantial Acquisition Of Sh
Key fundamentals
Evaluate the intrinsic value of Sanjivani Paranteral Ltd stock
| Name | March-26 | March-25 | March-24 | March-23 | March-22 |
|---|---|---|---|---|---|
| Assets | 57.5417 | 43.6252 | 28.8678 | -0.5776 | -4.8343 |
| Liabilities | 57.5417 | 43.6252 | 28.8678 | -0.5776 | -4.8343 |
| Equity | 12.2843 | 11.8816 | 11.6843 | 9.9983 | 9.9983 |
| Gross Profit | 9.3977 | 10.36 | 8.241 | 5.6372 | 5.7258 |
| Net Profit | 6.9232 | 8.1018 | 6.1651 | 4.5115 | 4.8464 |
| Cash From Operating Activities | -1.5526 | -0.2385 | -10.7033 | 4.6843 | 8.5198 |
| NPM(%) | 10.68 | 11.55 | 11.33 | 12.71 | 15.83 |
| Revenue | 64.7639 | 70.0986 | 54.4105 | 35.4915 | 30.6126 |
| Expenses | 55.3662 | 59.7385 | 46.1695 | 29.8543 | 24.8867 |
| ROE(%) | 14.34 | 16.79 | 12.77 | 9.35 | 10.04 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|
Peers
Other companies within the same industry or sector that are comparable to Sanjivani Paranteral Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Albert David Ltd | 725.00 | 4.05 | 0.00 | 79.99 | -26.19 | 0.69 |
| Lotus Eye Hospital and Institute Ltd | 133.50 | -0.45 | 4503.33 | 291.46 | 0.39 | 0.00 |
| Bharat Immunological and Biologicals Corporation Ltd | 17.01 | 1.13 | 0.00 | 605.17 | -39.50 | 0.00 |
| Astec Lifesciences Ltd | 769.00 | -0.20 | 0.00 | 274.85 | -363.14 | 0.00 |
Company Info
SANJIVANI PARANTERAL LTD. was incorporated as a Public Limited Company with Registrar of Companies, Maharashtra. The Company obtained Certificate of incorporation on 05/10/1004 and Certificate for Commencement of Business on 24/11/1994. The Company is jointly promoted by a team of professionals in various fields of Pharmaceutical industry. Mr. Anami H. Khemka aged 52 years, is associated with Pharmaceutical industry for last more than 10 years with specialisation in Marketing and Exports. He has wide experience of business in general and Marketing in particular. He has good commercial relations with first line Pharmaceutical companies. His entrepreneurship can be guaged from the fact that he had taken over a sick unit M/s. Sanjeevanee Pharmaceuticals Pvt. Ltd. and in a short period of three years converted the sick unit into a totally healthy profitable unit. 2004 -Company has Bagged order for the supply of 3 million Units of Cephalosporin to CIS Market. 2005 -Company has received the order of approx. Rs 316.80 million from Kerela Government. 2006 -Company has added milestone by securing the bid of CMS Tender of West Bengal Government for bulk supply to all the Hospitals of West Bengal Government -Company has bagged the prestigious order of Mumbai Municipal Corporation 2007 -Sanjivani Paranteral Ltd has has entered in the rate contracts with Defence Ministry of India for three years. Initial order received for Rs 5.00 Cr. which has to be executed in Feb'07 itself. -Company has launched new product of the Company namely SANCIDAL 2008 -Company has acquired a new pharmaceutical manufacturing plant in Uttarakhand.2025-The Company Started Commercial production at IV Fluid Infusion Plant.
SANJIVANI PARANTERAL LTD. was incorporated as a Public Limited Company with Registrar of Companies, Maharashtra. The Company obtained Certificate of incorporation on 05/10/1004 and Certificate for Commencement of Business on 24/11/1994. The Company is jointly promoted by a team of professionals in various fields of Pharmaceutical industry. Mr. Anami H. Khemka aged 52 years, is associated with Pharmaceutical industry for last more than 10 years with specialisation in Marketing and Exports. He has wide experience of business in general and Marketing in particular. He has good commercial relations with first line Pharmaceutical companies. His entrepreneurship can be guaged from the fact that he had taken over a sick unit M/s. Sanjeevanee Pharmaceuticals Pvt. Ltd. and in a short period of three years converted the sick unit into a totally healthy profitable unit. 2004 -Company has Bagged order for the supply of 3 million Units of Cephalosporin to CIS Market. 2005 -Company has received the order of approx. Rs 316.80 million from Kerela Government. 2006 -Company has added milestone by securing the bid of CMS Tender of West Bengal Government for bulk supply to all the Hospitals of West Bengal Government -Company has bagged the prestigious order of Mumbai Municipal Corporation 2007 -Sanjivani Paranteral Ltd has has entered in the rate contracts with Defence Ministry of India for three years. Initial order received for Rs 5.00 Cr. which has to be executed in Feb'07 itself. -Company has launched new product of the Company namely SANCIDAL 2008 -Company has acquired a new pharmaceutical manufacturing plant in Uttarakhand.2025-The Company Started Commercial production at IV Fluid Infusion Plant.
Read More
Parent Organisation
Sanjivani Paranteral Ltd.
Founded
05/10/1994
Managing Director
Mr.Ashwani Khemka
NSE Symbol
FAQ
The current price of Sanjivani Paranteral Ltd is
The 52-week high for Sanjivani Paranteral Ltd is
The market capitalization of Sanjivani Paranteral Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Sanjivani Paranteral Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Sanjivani Paranteral Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Sanjivani Paranteral Ltd shares.
The CEO of Sanjivani Paranteral Ltd is Mr.Ashwani Khemka, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.
